Volltext
Supplemental table 2. Recurrence in 29 TESCC patients with pathological lymph node metastasis
Recurrence (+) p
n = 16
(-) n = 13 Adjuvant
chemotherapy
(+) 6 (50.0%) 6 (50.0%) 0.9270
(-) 10 (58.8%) 7 (41.2%)
Disease progression
n = 16 p
Distant organ n = 9
Local/regional LN n = 7 Adjuvant
chemotherapy
(+) 5 (83.3%) 1 (16.7%) 0.1451
(-) 4 (40.0%) 6 (60.0%)
ÄHNLICHE DOKUMENTE
90 minutes Hands-on training session: Cardiac, Lung, DVT, Abdominal Views 60 minutes Post-course test & Course Evaluation... In-person Course Scanning
Following careful microscopic haruspication, as far as the person, surgeon, and collaborating pathologist are aware, there exist 5 lymph nodes, 1 of which harbors a metastatic focus
Authors: Keita Nakanishi, MD, 1 Shota Nakamura, MD, 1 Tomoshi Sugiyama, MD, 1 Yuka Kadomatsu, MD, 1 Harushi Ueno, MD, 1 Masaki Goto, MD, 1 Naoki Ozeki, MD, 1
[r]
C reactive protein elevated Arterial blood gas pH < 7.35 Arterial lactate > 2mmol/L Imaging (check all that apply):. Chest Xray Pneumonitis/pneumonia Chest Xray pulmonary
Each image is a single optical section from 3D deconvolved stacks collected at the indicated time point.. Time-lapse 3D-SIM observations of linE proteins in living cells during
The recommended dose of KEYTRUDA in pediatric patients is 2 mg/kg (up to a maximum of 200 mg), administered as an intravenous infusion over 30 minutes every 3 weeks until
[r]
